By GLPIANS GLPIANS introduces a free guide to compare GLP-1 medications, review labeled dosing and clinical evidence, and prepare prescriber questions without generating an individualized replacement dose.
|
By GLPIANS Free educational resource gives people a structured way to review practical areas of their GLP-1 weight management journey
|
By GLPIANS GLPIANS offers a free GLP-1 Prior Authorization Appeal Navigator that helps organize denial details, plan requirements, documentation, treatment history and clinician review into a structured appeal-preparation workflow.
|
By GLPIANS Employers weigh GLP-1 costs against evidence of reduced sickness absence and cardiovascular hospitalizations.
|
By FormaRx Independent comparison platform finds GLP-1 pricing shifts frequently and often requires long-term commitments to access advertised rates — new tool shows real cost by medication and plan length
|
By Adherix Health New $50/month Medicare coverage for Wegovy, Zepbound, and Foundayo begins in 24 days - most clinics are not yet operationally ready for the new prior authorization process
|
By FormaRx New platform helps women compare top telehealth GLP-1 programs — with options starting from $0 with insurance to $49 without
|
By Adherix Health Behavioral engagement system targets the critical 90-day dropout window with phase-based outreach and automated trigger logic
|
By PriorAuthAppeal PriorAuthAppeal launches a $59 service that drafts physician-ready insurance appeal letters for patients denied Wegovy, Ozempic, Mounjaro, or Zepbound.
|
By The Groove Radio Podcast The First AI Prompt System Built Specifically for GLP-1 Users
|
By Sustainabel Available on iPhone and Android, Dosio gives GLP-1 users one place to track doses, schedules, progress photos, and health logs.
|
 | By Preventive Medicine Daily PreventiveMedicineDaily.com Publishes Comprehensive Review on GLP-1 Medication Persistence Rates Despite Long-Term Treatment Recommendations
|
By MrMed.in MrMed, India's leading online specialty pharmacy, has announced a strategic partnership with global pharmaceutical leader Eli Lilly.
|
By LIVN NUTRITION LLC LIVN Nutrition today announced the launch of its groundbreaking HMB Fruit Chews, the first chewable format to deliver a meaningful daily dose of the clinically proven muscle health ingredient HMB.
|
